Additional Information

1. U.S. Research Reports: The Therapeutics of Soybean Phytochemicals,

A collection of international research demonstrates the value of using the Biological Response Modifier capabilities of soybean phytochemicals as adjuvant nutrition to eliminate protein calorie malnutrition... and to support, extend and improve the quality of life for patients with cancer, cachexia, leukemia, HIV (AIDS), and other chronic diseases where the inducement of non-toxic immunostimulation, anti-angiogenesis, and anti-viral serum conditions are beneficial to the patient.

The complete document is 140 pages in length.

Go to or call US Research Reports at tollfree (800) 533-9660 and request a copy.

2. Townsend Letter for Doctors: Surviving Cancer with Fermented Soy by Vjaya Nair, MD, FAMS, MS, 11/2004,

Dietary Supplementation with Fermented soy Nutraceutical, Haelan951 in Patients who survived Terminal Cancers. Seven case studies including 

1)infiltrating ductal carcinoma of the breast,

2) infiltrating ductal carcinoma with history of lymphangitic spread, metastases to skin, lungs, bronchi, pericardium and bones, 

3) poorly differentiated adenocarcinoma of the gallbladder, 

4) myeloproliferative disorder, 

5) follicular lymphoma, grade 2, 

6) prostate cancer, 

7) infitrating adenocarcinoma of the prostate.

Conclusion: Significant benefits are associated with the dietary supplementation of fermented soy such as Haelan 951 for patients diagnosed with cancers, either alone or in conjunction with conventional chemotherapy. 

3. Haelan Stabilization of Platinum Resistant Ovarian Cancer, Massachusetts General Hospital, May 2005

4. The Effect of Fermented Soy on Blood Hematology and Cachexia in Cancer Patients, Uwe Rohr, MD, PhD, MED 19  Medical Center, Austria, Walter Wainright, Haelan Research Foundation

5. Effects of Combined Treatment with Haelan 951 and Doxorubicin on the Breast Cancer Cell Line BT474, Doris Bachg, MD, PhD and Uwe Haselhorst, MD, Germany

6. The Effects of Haelan 951 as monotherapy and as a combined treatment with Doxorubicin (Adriamycin) chemotherapy on invasive ductile carcinoma breast cancer cell line BT 474, Haelan Research Foundation

 7. Haelan 951 Improves Results of Chemotherapy / Radiation Treatments, Karmanos Cancer Institute, Wayne State University School of Medicine

8. Go to  This is a complete list of all research and studies conducted on Haelan 951.